pimavanserin

Term ID

CHEBI:133017

Synonyms

N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide
N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea
pimavanserin

Definition

A member of the class of ureas in which three of the four hydrogens are replaced by 4-fluorobenzyl, 1-methylpiperidin-4-yl, and 4-(isopropyloxy)benzyl groups. An atypical antipsychotic that is used (in the form of its tartrate salt) for treatment of hallucinations and delusions associated with Parkinson's disease.

References

cas:706779-91-1
drugcentral:5142
patent:CA2652300
pubmed:16469866
pubmed:19040345
pubmed:19864614
pubmed:19907417
pubmed:21256805
pubmed:21921840
pubmed:22750845
pubmed:22954754
pubmed:23969614
pubmed:24016069
pubmed:24183563
pubmed:24183566
pubmed:24247322
pubmed:24292660
pubmed:24682754
pubmed:25655720
pubmed:26744739
pubmed:26908168
pubmed:27242287
pubmed:27245248
pubmed:27249096
pubmed:27261226
pubmed:27262680
pubmed:27503570
reaxys:10386699
wikipedia.en:Pimavanserin

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from pimavanserin

Phenotype where environments contain pimavanserin

Phenotype modified by environments containing pimavanserin

Phenotype affecting pimavanserin

Human Disease Model